Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

201436 citationsJournal Articlegold Open Access

Authors

http://www.clinicaltrials.gov: NCT00422773.

Good health and well-being

Published in: BMC Cancer

Volume 14, Issue 1, pp. 521-521

Field-Weighted Citation Impact: 1.34